Storys aus Amsterdam

Filtern
  • 25.01.2022 – 10:01

    Atradius N.V.

    Atradius: Covid-19 continues to hobble global economy

    Amsterdam (ots/PRNewswire) - The strong rebound in GDP across most of the world may prove to be more of a bounce than a movement. Purchasing power, bolstered in many cases by government intervention was strong in 2021. Despite strong product demand, supply chain issues have left factory shelves depleted and driven inflation sky high. In the US, the inflation rate hit 4.6%, the highest of the developed markets, and is ...

  • 20.01.2022 – 10:01

    Atradius N.V.

    Atradius: Food & Beverages industry vulnerable to downside risks in 2022

    Amsterdam (ots/PRNewswire) - Industry report from Atradius reveals major growth drivers and constraints in the Food & Beverages industry across multiple markets worldwide A number of downside risks are expected to pose major challenges to the global Food & Beverages sector this year. Sharp increases in commodity and energy prices, labour shortages, transport issues and ...

  • 22.12.2021 – 07:00

    Finch Capital

    Finch Capital's annual FinTech predictions for 2022

    Amsterdam (ots/PRNewswire) - Finch Capital's forward-looking vision on the European FinTech space, 11 predictions that will shape the space in 2022 Today, Finch Capital issued their 2022 predictions (visit predictions report here) for European FinTech. The predictions summarizes and compiles industry data from various databases and research institutions. It also includes the Finch team's own perspectives on the market, ...

  • 17.12.2021 – 10:01

    Norgine

    Norgine B.V. announces Senior Management changes: Christopher Bath appointed Chief Executive Officer - Peter Stein to assume role of Executive Chairman

    Amsterdam (ots/PRNewswire) - Norgine B.V. (Norgine), a leading European specialist pharmaceutical company, today announces that Christopher Bath has been appointed Chief Executive Officer (CEO) effective 1st January 2022. Chris will be responsible for a business with a portfolio of market leading medicinal products ...

  • 06.12.2021 – 07:01

    Odyssey; BenevolentAI

    Odyssey Announces Agreement to Combine with BenevolentAI

    London and Amsterdam (ots/PRNewswire) - - BenevolentAI is a leading, clinical-stage AI drug discovery company that combines advanced AI and machine learning with cutting edge science to discover and develop novel and more effective medicines - Combination of BenevolentAI with Odyssey, a EUR300m Euronext Amsterdam-listed special purpose acquisition company focused on European healthcare and technology, represents the ...